Genetic aspects of pituitary tumors

A. Spada

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Pituitary adenomas arise from the replication of a single mutated cell in which growth advantage may result from either activation of protooncogenes or inactivation of antioncogenes. The search for oncogenes in the genesis of these tumors has yielded negative results except for the gsp oncogene, that has been identified in about 30-40% of GH-secreting adenomas. gsp mutations cause constitutive activation of the Gs alpha subunit, leading to elevated cAMP formation and growth hormone hypersecretion. In the remaining tumor types several lines of evidence suggest that genes implicated in cell proliferation, such as early immediate genes, growth factors and growth factor receptors, are over-expressed. As far as the loss of antioncogenes in pituitary adenomas is concerned, no inactivating mutations of these genes have yet been identified in pituitary adenomas. However, despite the lack of mutations, several antioncogenes proteins have been detected at extremely low levels in pituitary adenomas, consistent with a possible role of these tumor suppressors in pituitary tumor formation.

Original languageEnglish
Pages (from-to)1213-1216
Number of pages4
JournalJournal of Pediatric Endocrinology and Metabolism
Volume14
Issue numberSUPPL. 5
Publication statusPublished - 2001

Fingerprint

Pituitary Neoplasms
Tumor Suppressor Genes
Oncogenes
Mutation
Neoplasms
Immediate-Early Genes
Growth Factor Receptors
Adenoma
Growth Hormone
Genes
Intercellular Signaling Peptides and Proteins
Cell Proliferation
Growth
Proteins

Keywords

  • Antioncogenes
  • Growth factors
  • gsp oncogene
  • Pituitary tumors

ASJC Scopus subject areas

  • Endocrinology
  • Pediatrics, Perinatology, and Child Health

Cite this

Genetic aspects of pituitary tumors. / Spada, A.

In: Journal of Pediatric Endocrinology and Metabolism, Vol. 14, No. SUPPL. 5, 2001, p. 1213-1216.

Research output: Contribution to journalArticle

Spada, A 2001, 'Genetic aspects of pituitary tumors', Journal of Pediatric Endocrinology and Metabolism, vol. 14, no. SUPPL. 5, pp. 1213-1216.
Spada, A. / Genetic aspects of pituitary tumors. In: Journal of Pediatric Endocrinology and Metabolism. 2001 ; Vol. 14, No. SUPPL. 5. pp. 1213-1216.
@article{3368943ef97d4adbb6b943fc680fb6b1,
title = "Genetic aspects of pituitary tumors",
abstract = "Pituitary adenomas arise from the replication of a single mutated cell in which growth advantage may result from either activation of protooncogenes or inactivation of antioncogenes. The search for oncogenes in the genesis of these tumors has yielded negative results except for the gsp oncogene, that has been identified in about 30-40{\%} of GH-secreting adenomas. gsp mutations cause constitutive activation of the Gs alpha subunit, leading to elevated cAMP formation and growth hormone hypersecretion. In the remaining tumor types several lines of evidence suggest that genes implicated in cell proliferation, such as early immediate genes, growth factors and growth factor receptors, are over-expressed. As far as the loss of antioncogenes in pituitary adenomas is concerned, no inactivating mutations of these genes have yet been identified in pituitary adenomas. However, despite the lack of mutations, several antioncogenes proteins have been detected at extremely low levels in pituitary adenomas, consistent with a possible role of these tumor suppressors in pituitary tumor formation.",
keywords = "Antioncogenes, Growth factors, gsp oncogene, Pituitary tumors",
author = "A. Spada",
year = "2001",
language = "English",
volume = "14",
pages = "1213--1216",
journal = "Journal of Pediatric Endocrinology and Metabolism",
issn = "0334-018X",
publisher = "Walter de Gruyter GmbH & Co. KG",
number = "SUPPL. 5",

}

TY - JOUR

T1 - Genetic aspects of pituitary tumors

AU - Spada, A.

PY - 2001

Y1 - 2001

N2 - Pituitary adenomas arise from the replication of a single mutated cell in which growth advantage may result from either activation of protooncogenes or inactivation of antioncogenes. The search for oncogenes in the genesis of these tumors has yielded negative results except for the gsp oncogene, that has been identified in about 30-40% of GH-secreting adenomas. gsp mutations cause constitutive activation of the Gs alpha subunit, leading to elevated cAMP formation and growth hormone hypersecretion. In the remaining tumor types several lines of evidence suggest that genes implicated in cell proliferation, such as early immediate genes, growth factors and growth factor receptors, are over-expressed. As far as the loss of antioncogenes in pituitary adenomas is concerned, no inactivating mutations of these genes have yet been identified in pituitary adenomas. However, despite the lack of mutations, several antioncogenes proteins have been detected at extremely low levels in pituitary adenomas, consistent with a possible role of these tumor suppressors in pituitary tumor formation.

AB - Pituitary adenomas arise from the replication of a single mutated cell in which growth advantage may result from either activation of protooncogenes or inactivation of antioncogenes. The search for oncogenes in the genesis of these tumors has yielded negative results except for the gsp oncogene, that has been identified in about 30-40% of GH-secreting adenomas. gsp mutations cause constitutive activation of the Gs alpha subunit, leading to elevated cAMP formation and growth hormone hypersecretion. In the remaining tumor types several lines of evidence suggest that genes implicated in cell proliferation, such as early immediate genes, growth factors and growth factor receptors, are over-expressed. As far as the loss of antioncogenes in pituitary adenomas is concerned, no inactivating mutations of these genes have yet been identified in pituitary adenomas. However, despite the lack of mutations, several antioncogenes proteins have been detected at extremely low levels in pituitary adenomas, consistent with a possible role of these tumor suppressors in pituitary tumor formation.

KW - Antioncogenes

KW - Growth factors

KW - gsp oncogene

KW - Pituitary tumors

UR - http://www.scopus.com/inward/record.url?scp=0035188442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035188442&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 1213

EP - 1216

JO - Journal of Pediatric Endocrinology and Metabolism

JF - Journal of Pediatric Endocrinology and Metabolism

SN - 0334-018X

IS - SUPPL. 5

ER -